申请人:——
公开号:US20040010023A1
公开(公告)日:2004-01-15
The invention relates to novel biphenyl derivatives of the general formula (I), wherein R
4
represents an aromatic heterocycle, and to the physiologically acceptable salts or solvates thereof. The inventive compounds are integrin inhibitors and are used for combating thromboses, cardiac infarction, coronary heart diseases, arteriosclerosis, inflammations, tumors, osteoporosis, infections and restenosis following angioplasty or for pathological processes that are maintained or propagated by angiogenesis.
1
该发明涉及一种通式(I)的新型联苯衍生物,其中R4代表芳香杂环,并且其生理上可接受的盐或溶剂化合物。这些创新化合物是整合素抑制剂,用于对抗血栓形成、心肌梗死、冠心病、动脉粥样硬化、炎症、肿瘤、骨质疏松症、感染以及在血管成形术后再狭窄或由血管生成维持或传播的病理过程。